Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514312, 514314, 546153, A61K 3140, A61K 3145, C07D21560
(1H-azol-1-ylmethyl)substituted quinoline derivatives, compositions containing the same, and methods of treating mammals suffering from disorders which are characterized by an increased proliferation and/or abnormal differentiation of epithelial tissues.
patent: 4792561 (1988-12-01), Walker et al.
patent: 5185346 (1993-02-01), Sanz et al.
patent: 5268380 (1993-12-01), Sanz et al.
Freyne Eddy J. E.
Raeymaekers Alfons H. M.
Sanz Gerard C.
Venet Marc G.
Ivy C. Warren
Janssen Pharmaceutica N. V.
Metz Charles J.
(1h-azol-1-ylmethyl) substituted quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with (1h-azol-1-ylmethyl) substituted quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1h-azol-1-ylmethyl) substituted quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2181929